Metabolism & Fat BurningTirzepatide
Dual GIP/GLP-1 receptor agonist.
/
Metabolism & Fat BurningResearch Peptide
Triple GLP-1/GIP/Glucagon receptor agonist.
Product Type
Dosage
Price
€96
For research use only. Not for human consumption.
Retatrutide is an advanced triple receptor agonist designed for next-generation metabolic research. By targeting GLP-1, GIP, and glucagon receptor pathways simultaneously, Retatrutide represents one of the most innovative compounds investigated in modern metabolic science.
Intended for laboratory environments that require precise and reliable research materials, Retatrutide supports investigations into multi-receptor signaling, energy metabolism, and endocrine pathway interactions.
Each batch is prepared to research-grade standards and independently assessed to support consistency, purity, and experimental reproducibility.
Store refrigerated between 2–8°C before reconstitution. Protect from direct light, excessive heat, and moisture. Maintain appropriate laboratory storage conditions according to established research handling procedures.
This product is intended strictly for scientific and laboratory research purposes only. It is not intended for human consumption, clinical use, diagnosis, treatment, or prevention of any disease.
For research use only. Not for human consumption.
Metabolism & Fat BurningDual GIP/GLP-1 receptor agonist.
Metabolism & Fat BurningLong-acting GLP-1 receptor agonist.
Metabolism & Fat BurninghGH Fragment 177-191 peptide.